Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

RECOMMENDED

Multiple Sclerosis

Peripheral CD19⁺ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders

J Neurol.

Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A

doi: 10.1007/s00415-018-9092-4.

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

Multiple Sclerosis

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis

Sci Rep.

Friess J, Hecker M, Roch L, Koczan D, Fitzner B, Angerer IC, Schröder I, Flechtner K, Thiesen HJ, Winkelmann A, Zettl UK

doi: 10.1038/srep42087.

Multiple Sclerosis

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Brain.

Correale J, Gaitán MI, Ysrraelit MC, Fiol MP

doi: 10.1093/brain/aww258.

RECOMMENDED

Multiple Sclerosis

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Eur Neurol.

Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö

doi: 10.1159/000495798.

Multiple Sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Brain

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J

doi: 10.1093/brain/awy154.

Multiple Sclerosis

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Brain.

Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL

doi: 10.1093/brain/awz212.

Multiple Sclerosis

Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis

JAMA Neurol.

Knier B, Leppenetier G, Wetzlmair C, Aly L, Hoshi MM, Pernpeintner V, Biberacher V, Berthele A, Mühlau M, Zimmer C, Hemmer B, Korn T

doi: 10.1001/jamaneurol.

Multiple Sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

J Neuroinflammation.

Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI

doi: 10.1186/s12974-018-1295-1.

Related content

Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders

Vaccination Readiness in Multiple Sclerosis

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

Peripheral CD19⁺ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders